Clinical Trial Update: A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial of SB1518 in advanced lymphoid malignancies assessed safety and efficacy in Hodgkin lymphoma, mantle cell lymphoma, and indolent non-Hodgkin lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Indolent Non-hodgkin Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• SB1518

Snippet

Sponsor: S*BIO | Conditions: Hodgkin Lymphoma, Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED